Deutsche Bank Aktiengesellschaft »

Denali Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.5M 115k 21.45
2023-09-30 $2.4M 117k 20.63
2023-06-30 $4.3M 145k 29.51
2023-03-31 $3.0M 131k 23.04
2022-12-31 $3.1M 111k 27.81
2022-09-30 $3.2M 101k 31.75
2022-06-30 $3.5M 110k 31.75
2022-03-31 $3.6M 113k 31.75
2021-12-31 $5.0M 118k 42.33
2021-09-30 $5.9M 116k 50.44
2021-06-30 $9.2M 117k 78.43
2021-03-31 $3.4M 59k 57.08
2020-12-31 $4.4M 52k 83.89
2020-09-30 $1.5M 41k 36.00
2020-06-30 $1.0M 42k 24.12
2020-03-31 $1.2M 71k 17.59
2019-12-31 $1.4M 84k 17.04
2019-09-30 $1.5M 104k 14.81
2019-06-30 $1.0M 49k 20.59
2019-03-31 $562k 26k 21.36
2018-12-31 $561k 27k 20.65
2018-09-30 $2.1M 103k 19.92
2018-06-30 $416k 27k 15.16
2018-03-31 $345k 18k 19.67